Posts Tagged ‘March 29’
BREXIT AND TAX: WHAT’S IN STORE FOR BIOTECHS?
THERE IS no doubt that biotech fundraising rounds are getting bigger, companies are getting bigger and, as tax advisors, we are being faced with previously unheard of issues. Take profits – these could result in corporation tax liabilities, groups so large or profitable that they cannot claim SME R&D tax credits or future milestone income…
Read More